Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: Results of a randomized double-blind trial Journal of Clinical Oncology April 1997;15(4):1617-1623
Date
01/01/1997
DOI
10.1200/JCO.1997.15.4.1617Scopus ID
2-s2.0-0031003466 (requires institutional sign-in at Scopus site)
17 CitationsAuthor List
Vose JM, Pandite AN, Beveridge RA, Geller RB, Schuster MW, Anderson JE, LeMaistre CF, Ahmed T, Granena A, Keating A, Fernadez Ranada JM, Stiff PJ, Tabbara I, Longo W, Copelan EA, Nichols C, Smith A, Topolsky DL, Bierman PJ, Lebsack ME, Lange M, Garrison L
Author
Walter L. Longo MD Professor in the Medicine department at Medical College of Wisconsin